Drug Search by Year (Detail)

24959785

CA

Peripheral swelling, Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Confusional state, Condition aggravated, Contusion, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Live birth, Urticaria, Paraesthesia, Peripheral swelling, Peripheral venous disease, Rheumatic fever, Sleep disorder, Stomatitis, Taste disorder, Infusion related reaction, Underdose, Off label use, Maternal exposure during pregnancy, Treatment failure, Intentional product use issue, Exposure during pregnancy, Drug intolerance, Drug ineffective, Contraindicated product administered, Product quality issue, Therapeutic product effect decreased, Therapeutic product effect incomplete, Lower respiratory tract infection, Helicobacter infection, Decreased appetite, Type 2 diabetes mellitus, Urticaria, Weight increased, Wheezing, Wound infection,

SARILUMAB,

24960331

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24960631

US

General physical health deterioration, Living in residential institution,

PIMAVANSERIN TARTRATE,

24960712

CA

General physical health deterioration, Asthenia, Cognitive disorder, Confusional state, Delirium, Fall, Fatigue, Hyperhidrosis, Multiple organ dysfunction syndrome, Pyrexia, Respiratory distress, Wrong technique in product usage process,

HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS,

24960863

US

Tachycardia, General physical health deterioration,

LUTETIUM LU 177 DOTATATE,

24960972

CA

Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Loss of personal independence in daily activities, Product label confusion, Product quality issue, Product use in unapproved indication, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection,

BUPRENORPHINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, TOFACITINIB, TOFACITINIB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ADALIMUMAB, ADALIMUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, NAPROXEN, NAPROXEN SODIUM,

24961060

CA

Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bursitis, C-reactive protein, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Off label use, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pregnancy, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder due to general medical condition, hypersomnia type, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tender joint count, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound,

SARILUMAB,

24961123

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24961138

CA

Breast cancer stage III, Liver injury, Duodenal ulcer perforation, Epilepsy, Hand deformity, Lower respiratory tract infection, Psoriatic arthropathy, Pemphigus, Pericarditis, Rheumatoid arthritis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Abdominal pain upper, Condition aggravated, C-reactive protein increased, Blood cholesterol increased, Confusional state, Blister, Blepharospasm, Asthenia, Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Bursitis, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Headache, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Lung disorder, Memory impairment, Migraine, Mobility decreased, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Peripheral swelling, Peripheral venous disease, Rash, Stomatitis, Swelling, Synovitis, Taste disorder, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Contraindicated product administered, Maternal exposure during pregnancy, Exposure during pregnancy, Product quality issue,

MIRABEGRON, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, RITUXIMAB, RITUXIMAB, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, LEFLUNOMIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE,

24961260

JP

Neoplasm malignant, General physical health deterioration,

LEVOCETIRIZINE DIHYDROCHLORIDE, SUVOREXANT,

24961275

CA

Abdominal discomfort, Abdominal pain, Alopecia, Arthralgia, Back pain, Blood pressure increased, COVID-19, Cholelithiasis, Cheilitis, Cholangitis sclerosing, Crohn^s disease, Constipation, Decreased appetite, Defaecation urgency, Diarrhoea, Discomfort, Dizziness, Dyspepsia, Faecal calprotectin abnormal, Fatigue, Flank pain, Flatulence, Frequent bowel movements, Gastric ulcer, Gastrointestinal disorder, General physical health deterioration, Haematochezia, Hepatic enzyme increased, Ileal ulcer, Mouth ulceration, Obstructive sleep apnoea syndrome, Oesophageal pain, Oesophageal ulcer, Oral pain, Oropharyngeal pain, Pain, Rash, Sinusitis, Skin lesion, Stomatitis, Therapeutic product effect incomplete, Ulcer, Weight increased, Concussion, Diabetes mellitus, Fall, Off label use,

INFLIXIMAB, INFLIXIMAB, BUDESONIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM,

24961505

BR

General physical health deterioration,

SORAFENIB, HYDROXYZINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LORATADINE, LORATADINE ORAL, VITAMIN C, ERGOCALCIFEROL, NEOMYCIN OINTMENT, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PROPRANOLOL HYDROCHLORIDE, SIMVASTATIN,

24961596

CO

Abdominal pain, Upper gastrointestinal haemorrhage, Lower gastrointestinal haemorrhage, General physical health deterioration,

DURVALUMAB,

24961696

US

General physical health deterioration,

LUTETIUM LU 177 DOTATATE,

24961855

RO

General physical health deterioration, Pancreatitis acute, Pancreatic abscess, Respiratory distress, Pulmonary embolism, COVID-19, Tachycardia, Dyspnoea,

BRENTUXIMAB VEDOTIN, PREDNISONE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, BLEOMYCIN, BLEOMYCIN SULFATE, DACARBAZINE, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, NIVOLUMAB,

24961866

US

General physical health deterioration,

LUTETIUM LU 177 DOTATATE,

24962210

DE

General physical health deterioration,

LUTETIUM LU 177 DOTATATE,

24962419

CA

Adjustment disorder with depressed mood, Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adverse drug reaction, Adverse event, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back disorder, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Myositis, Nail disorder, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product quality issue, Product use in unapproved indication, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sleep disorder, Sleep disorder due to a general medical condition, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound infection, Wound, X-ray abnormal, Sinusitis, Bone erosion, Deep vein thrombosis postoperative, No adverse event,

OXYCODONE HYDROCHLORIDE, OXYCODONE, BUPRENORPHINE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLD, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CALCIUM CARBONATE, USTEKINUMAB, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, BOTULINUM TOXIN TYPE A, CANDESARTAN, CELECOXIB, CELECOXIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, VEDOLIZUMAB, NAPROXEN, NAPROXEN SODIUM, ERENUMAB-AOOE, ATOMOXETINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, PHENYLEPHRINE HYDROCHLORIDE, APREMILAST, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LORAZEPAM, CALCIUM, CALCIUM, CALCIUM, CAFFEINE CITRATE, CYANOCOBALAMIN, ERGOCALCIFEROL, ASIAN GINSENG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, LANSOPRAZOLE, LORAZEPAM, NICOTINAMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LANSOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, THIAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN A, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, LISINOPRIL, FISH OIL, SULFASALAZINE,

24962449

CA

Death, Infection, Decubitus ulcer, General physical health deterioration,

HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G,

24962558

DE

Death, General physical health deterioration,

24962599

SE

Melaena, General physical health deterioration, Hospitalisation,

24962679

DE

Confusional state, Hallucination, Musculoskeletal disorder, Clostridium test positive, Hallucination, auditory, Dysphagia, Diarrhoea, Cognitive disorder, Disorientation, Weight decreased, Dementia, General physical health deterioration, Motor dysfunction, General symptom, Parkinson^s disease, Benign prostatic hyperplasia, Osteoporosis, Spinal fusion surgery, Vascular dementia, Sinus arrest, Postoperative thoracic procedure complication, Microembolism, Hypertension, Dyslipidaemia, Hypochromic anaemia, Dysarthria, Apraxia, Oropharyngeal discomfort,

24962713

MX

Bacteraemia, Hyperprolactinaemia, General physical health deterioration, Leukocytosis,

HUMAN IMMUNOGLOBULIN G,

24952719

US

Cranial nerve disorder, Eye disorder, General physical health deterioration, Hypoacusis, Product storage error,

HUMAN INSULIN,

24952799

US

Epstein-Barr virus infection, General physical health deterioration,

OMALIZUMAB,

24952875

US

Infection, Dysstasia, Mobility decreased, Incoherent, Dysphagia, Motor dysfunction, Gait inability, Communication disorder, General physical health deterioration,

INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, BACLOFEN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MORPHINE SULFATE, LOSARTAN POTASSIUM, LOSARTAN,

24953106

US

General physical health deterioration,

OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SERTRALINE HYDROCHLORIDE, EMPAGLIFLOZIN, TADALAFIL, ALBUTEROL SULFATE, LISINOPRIL, OXYGEN, 0XYGEN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG,

24953340

CA

Anti-cyclic citrullinated peptide antibody, Abdominal discomfort, Adverse drug reaction, General physical health deterioration, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Blood cholesterol increased, Adverse event, Decreased appetite, Diarrhoea, Wound, Duodenal ulcer perforation, Fatigue, Fibromyalgia, Discomfort, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Infusion related reaction, Injury, Joint swelling, Liver injury, Malaise, Mobility decreased, Musculoskeletal stiffness, Pain, Pemphigus, Pericarditis, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Systemic lupus erythematosus, Type 2 diabetes mellitus, Treatment failure, Contraindicated product administered, Therapeutic product effect decreased, Exposure during pregnancy, Drug ineffective, Product use issue, Drug intolerance, Off label use, Maternal exposure during pregnancy, Anxiety, Asthma, Lupus vulgaris, Oedema peripheral, Pain in extremity, Product use in unapproved indication, Red blood cell sedimentation rate increased, Retinitis, Therapeutic product effect incomplete, Visual impairment,

SARILUMAB,

24953385

CA

Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Normal newborn, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus,

SARILUMAB,

24953440

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24953586

CA

Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal,

RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB,

24953608

CA

Platelet count abnormal, Asthenia, Discomfort, General physical health deterioration, Infusion site pain, Weight decreased, Off label use,

HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G,

24953798

CO

Secondary immunodeficiency, Pneumonia, Blood potassium increased, Blood creatinine increased, General physical health deterioration,

TACROLIMUS, TACROLIMUS, TACROLIMUS, TACROLIMUS, CLOPIDOGREL, CLOPIDOGREL BISULFATE, PREGABALIN, DESONIDE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION,

24953872

DE

Hospitalisation, Increased appetite, Abdominal pain, Muscular weakness, Cough, Dysgeusia, Dysphonia, Dizziness, Dysphonia, General physical health deterioration, Product dose omission issue,

AMIKACIN, AMIKACIN,

24953895

CA

Injection site reaction, Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blood cholesterol increased, Bursitis, C-reactive protein increased, Confusional state, Decreased appetite, Drug-induced liver injury, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Ill-defined disorder, Inflammation, Joint swelling, Mobility decreased, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Drug intolerance, Maternal exposure during pregnancy, Off label use, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure,

SARILUMAB,

24954031

SE

Somnolence, Urinary retention, Acute kidney injury, General physical health deterioration,

RISPERIDONE,

24954121

FR

General physical health deterioration, Cardiac failure, Pulmonary embolism, Dermatitis bullous, Dyspnoea, Diabetes mellitus inadequate control, Dermatitis, Asthenia, Fall, Oedema peripheral, Hypothalamic pituitary adrenal axis suppression, Product use issue, Product use in unapproved indication, Off label use,

HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, CANDESARTAN,

24954259

US

General physical health deterioration,

LUTETIUM LU 177 DOTATATE,

24954646

CA

Thrombosis, Haematemesis, Vaginal haemorrhage, Anal haemorrhage, Epistaxis, Nausea, Vomiting, Nausea, Infusion site haemorrhage, Malaise, Heavy menstrual bleeding, Product dose omission issue, Illness, Vomiting, Nausea, Product use issue, Epistaxis, Treatment delayed, Infusion related reaction, Product use issue, Fatigue, Infusion site pain, Infusion site pain, Pallor, Vomiting, Vomiting, Discomfort, Swelling, Vomiting, Haematemesis, Vomiting, Nausea, Neck pain, Ear swelling, General physical health deterioration, Vomiting, Haematochezia, Vaginal haemorrhage, Infusion site pain, Pallor, Respiratory tract infection, Cough, Oropharyngeal pain, Pyrexia, Illness, Discomfort,

24954743

SE

Nausea, Decreased appetite, Dizziness, General physical health deterioration,

OXYCODONE, AMLODIPINE BESYLATE, APIXABAN,

24954906

US

General physical health deterioration,

PIMAVANSERIN TARTRATE,

24955014

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24955124

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24955296

US

General physical health deterioration,

LUTETIUM LU 177 DOTATATE,

24955493

CA

Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Ill-defined disorder, Impaired healing, Infusion related reaction, Injury, Pericarditis, Rheumatoid arthritis, Systemic lupus erythematosus, Fatigue, Hypersensitivity, Hepatic enzyme increased, Infection, Helicobacter infection, Contraindicated product administered,

SARILUMAB, SARILUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE,

24955646

CA

Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme abnormal, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation,

ABATACEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, APREMILAST, LEFLUNOMIDE, LORAZEPAM, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, CYANOCOBALAMIN, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, FOLIC ACID, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LAMOTRIGINE, LANSOPRAZOLE, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, SULFASALAZINE, FISH OIL, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE,

24955650

CA

Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event,

ABATACEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, APREMILAST, LEFLUNOMIDE, LORAZEPAM, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, CYANOCOBALAMIN, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, FOLIC ACID, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IODINE, LAMOTRIGINE, LANSOPRAZOLE, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, SULFASALAZINE, FISH OIL, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE,

24955749

US

HIV infection, Hospitalisation, General physical health deterioration, Ear infection, Bone disorder, Rash,

DUPILUMAB, ERGOCALCIFEROL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, NIFEDIPINE, MONTELUKAST SODIUM, MONTELUKAST, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LORATADINE, LORATADINE ORAL, HALOPERIDOL, HALOPERIDOL LACTATE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, LOSARTAN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, LOSARTAN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS,

24955782

GB

Suicidal ideation, Condition aggravated, Mental disorder, General physical health deterioration, Apathy, Personality change, Social avoidant behaviour, Prescription drug used without a prescription, Hypotonia, Sexual dysfunction, Alopecia, Feeling abnormal, Emotional poverty, Malaise, Hypotonia, Depressive symptom,

FINASTERIDE,

24955808

General physical health deterioration, Myelofibrosis, Malignant neoplasm progression, Drug ineffective,

RUXOLITINIB,

24956189

CA

General physical health deterioration, Injection site pain, Arthralgia, Arthritis, Gout, Fibromyalgia, Arthropathy,

ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ,

24956282

CA

Lipoedema, Pneumonia, Alopecia, Chills, Conjunctivitis, Gastrointestinal inflammation, General physical health deterioration, Hypertension, Hyperhidrosis, Insomnia, Lymphoedema, Malaise, Malnutrition, Pain, Pain in extremity, Sinus disorder, Sleep disorder, Weight decreased, Pharyngitis, Arthralgia, Fatigue, Diarrhoea, Product dose omission issue, Inappropriate schedule of product administration,

USTEKINUMAB, CANDESARTAN,

24956367

CA

Crohn^s disease, Haematochezia, Gastric ulcer, Cholangitis sclerosing, Oesophageal ulcer, Ileal ulcer, Abdominal discomfort, Abdominal pain, Alopecia, Arthralgia, Back pain, Blood pressure increased, COVID-19, Cheilitis, Cholelithiasis, Constipation, Decreased appetite, Defaecation urgency, Diarrhoea, Discomfort, Dizziness, Dyspepsia, Faecal calprotectin abnormal, Fatigue, Flank pain, Flatulence, Frequent bowel movements, Gastrointestinal disorder, General physical health deterioration, Hepatic enzyme increased, Mouth ulceration, Obstructive sleep apnoea syndrome, Off label use, Pain, Sinusitis, Skin lesion, Stomatitis, Ulcer, Weight increased, Oesophageal pain, Concussion, Diabetes mellitus, Fall, Oral pain, Oropharyngeal pain, Rash, Therapeutic product effect incomplete,

BUDESONIDE, INFLIXIMAB, INFLIXIMAB, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE,

24956397

CA

Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Blister, Breast cancer stage II, Depression, Diarrhoea, Duodenal ulcer perforation, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Joint range of motion decreased, Maternal exposure during pregnancy, Pemphigus, Pericarditis, Rash, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Vomiting, Wheezing, Wound, Wound infection, Drug intolerance, Intentional product use issue, Live birth,

LAMOTRIGINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE,

24956479

ES

Unevaluable event, General physical health deterioration, Rash,

ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ,

24956638

CA

Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blood cholesterol increased, Bursitis, C-reactive protein increased, Confusional state, Decreased appetite, Drug intolerance, Drug-induced liver injury, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Ill-defined disorder, Inflammation, Injection site reaction, Joint swelling, Maternal exposure during pregnancy, Mobility decreased, Off label use, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection,

BUPRENORPHINE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, HYDROCORTISONE, HYDROCORTISONE, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, ERGOCALCIFEROL, ERGOCALCIFEROL, GOLIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ADALIMUMAB-ADAZ, INFLIXIMAB, SARILUMAB, LAMOTRIGINE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, RAMIPRIL, RANITIDINE HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, APREMILAST, APREMILAST, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN C, ERGOCALCIFEROL, USTEKINUMAB, USTEKINUMAB,

24956728

CA

Wound infection, Stomatitis, Sleep disorder, Rheumatoid arthritis, Product use in unapproved indication, Product quality issue, Pneumonia, Peripheral venous disease, Peripheral swelling, Pemphigus, Paraesthesia, Wheezing, Osteoarthritis, Onychomadesis, Obesity, Night sweats, Neck pain, Nasopharyngitis, Muscular weakness, Muscle spasms, Muscle injury, Lung disorder, Urticaria, Liver function test increased, Irritable bowel syndrome, Intentional product use issue, Infusion site reaction, Infusion related reaction, Impaired healing, Hypoaesthesia, Hypertension, Hypercholesterolaemia, Hepatic enzyme increased, Type 2 diabetes mellitus, Helicobacter infection, Glossodynia, General physical health deterioration, Gastrooesophageal reflux disease, Gait inability, Folliculitis, Fibromyalgia, Facet joint syndrome, Epilepsy, Duodenal ulcer perforation, Treatment failure, Dry mouth, Drug intolerance, Drug hypersensitivity, Dizziness, Depression, Contraindicated product administered, Confusional state, Therapeutic product effect decreased, Taste disorder, Systemic lupus erythematosus, Synovitis,

CANDESARTAN, CANDESARTAN, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYCODONE, RITUXIMAB,

24957284

CA

Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal,

ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, ETANERCEPT, ETANERCEPT, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, VITAMIN C, PREDNISONE, LORAZEPAM, CALCIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL,

24957318

CH

General physical health deterioration, Fall,

24959644

Pneumonia, Effusion, Cough, Chest pain, General physical health deterioration, Squamous cell carcinoma, Disease recurrence, Metastasis,

LENALIDOMIDE,

24960949

Nausea, Monkeypox, Disease progression, Immunosuppression, HIV infection, Refusal of treatment by patient, General physical health deterioration,

24946054

US

General physical health deterioration,

RAVULIZUMAB,

24946393

CA

Vomiting, Adverse reaction, Contraindicated product administered, Obesity, Onychomycosis, Pneumonia, Hepatic enzyme increased, Blepharospasm, Discomfort, Glossodynia, Peripheral venous disease, Asthenia, Breast cancer stage III, Fibromyalgia, Abdominal pain upper, Facet joint syndrome, Headache, Peripheral swelling, Dizziness, Hepatic enzyme, Off label use, Helicobacter infection, Urticaria, Gastrointestinal disorder, Wheezing, C-reactive protein increased, Drug ineffective, Product use in unapproved indication, Depression, Injection site reaction, Confusional state, Dry mouth, Coeliac disease, Weight increased, Hand deformity, Onychomadesis, Osteoarthritis, Paraesthesia, General physical health deterioration, Epilepsy, Blister, Grip strength decreased, Folliculitis, Wound, Product quality issue, Duodenal ulcer perforation, Taste disorder, Gait inability, Sleep disorder, Drug intolerance, Drug hypersensitivity, Wound infection, Swelling, Abdominal pain, Nasopharyngitis, Nail disorder, Musculoskeletal pain, Muscle spasms, Muscle injury, Migraine, Memory impairment, Lung disorder, Lower respiratory tract infection, Liver injury, Lip dry, Joint swelling, Joint range of motion decreased, Intentional product use issue, Type 2 diabetes mellitus, Systemic lupus erythematosus, Synovitis, Stomatitis, Rheumatoid arthritis, Rash, Psoriatic arthropathy, Pericarditis, Pemphigus, Pain, Night sweats, Insomnia, Irritable bowel syndrome, Injury, Infusion related reaction, Impaired healing, Hypoaesthesia, Hypertension, Hypercholesterolaemia, Hepatitis, Gastrooesophageal reflux disease, Finger deformity, Fatigue, Fall, Dyspepsia, Drug-induced liver injury, Diarrhoea, Condition aggravated, Bursitis, Blood cholesterol increased, Back injury, Arthropathy, Arthralgia, Anti-cyclic citrullinated peptide antibody positive, Alopecia, Abdominal discomfort, Abdominal distension, Inflammation,

CALCIUM CARBONATE, ANTACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CANDESARTAN, SECUKINUMAB, OXYCODONE, OXYCODONE, ETANERCEPT, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, SARILUMAB, SARILUMAB, NICOTINAMIDE, NICOTINAMIDE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN, NAPROXEN, NAPROXEN, NAPROXEN, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, RANITIDINE, RANITIDINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, APREMILAST, AZATHIOPRINE, AZATHIOPRINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, GOLD, HYDROCORTISONE BUTYRATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, TOFACITINIB, ACETAMINOPHEN AND CODEINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, DICLOFENAC SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, VITAMIN C, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY,

24946458

CA

Clostridium difficile infection, Mobility decreased, General physical health deterioration,

RITUXIMAB,

24946495

CA

Liver injury, Lung disorder, Pemphigus, Swollen joint count, Infusion related reaction, Inappropriate schedule of product administration, X-ray abnormal, Maternal exposure timing unspecified, Exposure during pregnancy, Glossodynia, Live birth, Musculoskeletal stiffness, Malaise, Hypersensitivity, Helicobacter infection, Hand deformity, Insomnia, Intentional product use issue, Urticaria, General physical health deterioration, Hypoaesthesia, Injury, Maternal exposure during pregnancy, Product use in unapproved indication, Nausea, Off label use, Pain, Hepatic enzyme increased, Joint swelling, Oedema,

DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, OXYCODONE, OXYCODONE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ADALIMUMAB-ADAZ,

24946807

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24946813

US

General physical health deterioration,

LUTETIUM LU 177 DOTATATE,

24946831

US

Emotional distress, General physical health deterioration,

DUPILUMAB,

24946912

US

General physical health deterioration,

LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE,

24946913

US

General physical health deterioration,

LUTETIUM LU 177 DOTATATE,

24946938

FR

General physical health deterioration, Starvation, Weight decreased, Fatigue, Diarrhoea, Cough, Gastroenteritis, Nausea, Arthralgia, Dizziness,

BEVACIZUMAB, PACLITAXEL, ATEZOLIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION,

24947424

CA

Exposure during pregnancy, Synovitis, Paraesthesia, Impaired healing, Joint swelling, Arthralgia, Muscle spasms, Pain, Infusion related reaction, Gastrooesophageal reflux disease, Hypocholesterolaemia, Irritable bowel syndrome, Headache, Hepatic enzyme increased, Peripheral swelling, Blepharospasm, Depression, Memory impairment, Peripheral venous disease, Weight increased, Wound, Joint range of motion decreased, Folliculitis, Night sweats, Dizziness, Taste disorder, Anti-cyclic citrullinated peptide antibody positive, Blood cholesterol increased, Dry mouth, Glossodynia, Lung disorder, Blister, Decreased appetite, General physical health deterioration, Vomiting, Migraine, Abdominal pain upper, Rash, Diarrhoea, Abdominal discomfort, Contraindicated product administered, Product quality issue,

ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, CANDESARTAN, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RITUXIMAB, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DICLOFENAC SODIUM, VITAMIN C, VITAMIN C, TOFACITINIB, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, FISH OIL,

24947430

US

General physical health deterioration, Petechiae, Lethargy, Amino acid level increased,

VIGABATRIN,

24947530

CA

Abdominal discomfort, Abdominal distension, Alopecia, Coeliac disease, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Condition aggravated, Dry mouth, Confusional state, Adverse reaction, Irritable bowel syndrome, Dizziness, Drug hypersensitivity, Dyspepsia, Drug-induced liver injury, Helicobacter infection, Duodenal ulcer perforation, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Hepatitis, Headache, Hepatic enzyme increased, Diarrhoea, Hypercholesterolaemia, Hypersensitivity, Hypoaesthesia, Hypotension, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Depression, Peripheral venous disease, Insomnia, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Drug intolerance, Drug ineffective, Contraindicated product administered, Maternal exposure during pregnancy, Off label use, Folliculitis, Intentional product use issue, Overdose, Peripheral venous disease, Pneumonia, Underdose,

SARILUMAB,

24947532

JP

Varicose vein ruptured, Cerebral infarction, Multiple organ dysfunction syndrome, Loss of personal independence in daily activities, General physical health deterioration,

BEVACIZUMAB, ATEZOLIZUMAB, APIXABAN,

24947604

CA

Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Folliculitis, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Pericarditis, Rheumatoid arthritis, Systemic lupus erythematosus, Gastrointestinal disorder, Arthralgia, Hepatic enzyme increased, Fatigue, Hypersensitivity, Exposure during pregnancy, Pain, Pemphigus, Product use issue,

CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, HYDROCORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, APREPITANT, FOSAPREPITANT DIMEGLUMINE, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ETANERCEPT, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, HYDROXYCHLOROQUINE SULFATE, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, GOLIMUMAB, GOLIMUMAB, TOCILIZUMAB,

24948169

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24948227

FR

Cerebral haemorrhage, Confusional state, General physical health deterioration, Anaemia, Thrombocytopenia, Blood alkaline phosphatase increased, Platelet count decreased, Adverse reaction,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, DENOSUMAB,

24948284

US

Transurethral prostatectomy, Cardiac ablation, General physical health deterioration, Post procedural infection,

EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT), EMPAGLIFLOZIN,

24948949

CA

Clostridium difficile infection, General physical health deterioration, Mobility decreased, Cataract operation, Hyperglycaemia, Hypoglycaemia, Nausea,

RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE,

24949020

AT

Cardiac failure acute, Proctalgia, Colonic fistula, Cardiomegaly, Stoma creation, Aspiration, Cardiomyopathy, Gastrointestinal inflammation, Intestinal stenosis, Emphysema, Anal fistula, Peritonitis, Intervertebral discitis, Colitis ulcerative, Frequent bowel movements, Colitis, General physical health deterioration, Weight decreased, Malnutrition, Gastrointestinal wall thickening, Frequent bowel movements, Crohn^s disease, General symptom, Diarrhoea, Osteitis, Abdominal pain,

ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB,

24949800

CA

Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Infusion related reaction, Ill-defined disorder, Impaired healing, Infection, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Peripheral swelling, Pruritus, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, Blister, Pericarditis, Pyrexia, Rash, Rheumatoid arthritis,

TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB,

24949846

CA

Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Drug ineffective, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Muscle injury, Migraine, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Off label use, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Drug intolerance, Epilepsy,

TOCILIZUMAB, RITUXIMAB, RITUXIMAB, LORAZEPAM, CALCIUM, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL,

24949853

CA

Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection,

SARILUMAB,

24950512

CA

Abdominal discomfort, Duodenal ulcer perforation, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Depression, Diarrhoea, Discomfort, Duodenal ulcer perforation, Delirium, Dislocation of vertebra, Dyspepsia, X-ray abnormal, Drug hypersensitivity, Dyspnoea, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Subcutaneous drug absorption impaired, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection,

SARILUMAB,

24950605

General physical health deterioration,

RUXOLITINIB,

24950654

US

Quality of life decreased, Agitation, Aggression, General physical health deterioration, Blood parathyroid hormone abnormal, Blood calcium abnormal, Therapy non-responder, Hospice care,

CINACALCET, CINACALCET HYDROCHLORIDE,

24950656

US

General physical health deterioration, Gait inability,

AMANTADINE, DONEPEZIL HYDROCHLORIDE, ZOLPIDEM TARTRATE,

24950965

CA

Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Blister, Blood cholesterol increased, Breast cancer stage III, Chest pain, Condition aggravated, Decreased appetite, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Duodenal ulcer perforation, Dyspnoea, Fatigue, Fibromyalgia, Gait disturbance, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Infection, Infusion related reaction, Injury, Joint range of motion decreased, Joint swelling, Live birth, Liver injury, Malaise, Memory impairment, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Pain, Pemphigus, Pericarditis, Psoriasis, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sleep disorder, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Vomiting, Walking aid user, Weight decreased, Wheezing, Wound, Wound infection, Contraindicated product administered, Drug ineffective, Drug intolerance, Intentional product use issue, Exposure during pregnancy, Maternal exposure during pregnancy, Off label use, Prescribed overdose, Product use in unapproved indication, Product use issue, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Treatment noncompliance,

SARILUMAB,

24951323

US

General physical health deterioration,

LUTETIUM LU 177 DOTATATE,

24951329

CA

Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Blister, Breast cancer stage III, Depression, Diarrhoea, Drug intolerance, Duodenal ulcer perforation, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Intentional product use issue, Joint range of motion decreased, Maternal exposure during pregnancy, Pemphigus, Pericarditis, Rash, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Vomiting, Wheezing, Wound, Wound infection,

RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE,

24951371

CA

Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Contraindicated product administered, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection,

TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB,

24952056

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24952081

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24945624

CA

Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rash, Rheumatoid arthritis, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, Pain, Contraindicated product administered,

CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CERTOLIZUMAB PEGOL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREPITANT, HYDROCORTISONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ETANERCEPT, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, OXYCODONE, PREDNISONE, PREDNISONE, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE, LEFLUNOMIDE, LEFLUNOMIDE,

24945724

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24945726

US

General physical health deterioration,

LUTETIUM LU 177 DOTATATE,

24945734

US

General physical health deterioration,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24946022

IT

General physical health deterioration, Aspartate aminotransferase increased, Mantle cell lymphoma, Leukocytosis,

IBRUTINIB,

24944407

DE

General physical health deterioration, Nephrolithiasis,

FOSCARBIDOPA/FOSLEVODOPA,